The neuroprotectant ebselen inhibits oxidative DNA damage induced by dopamine in the presence of copper ions

Neuroscience Letters

Volumn 330, Issue 1, 2002, Pages 69-73

  Li, Yunbo ^a   Cao, Zhuoxiao ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Copper ions; Dopamine; Ebselen; Neuroprotection; Oxidative DNA damage; Reactive oxygen species

Indexed keywords

COPPER ION; DOPAMINE; DOPAMINE QUINONE; EBSELEN; HYDROGEN PEROXIDE; NEUROPROTECTIVE AGENT; PLASMID DNA; QUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DEGENERATIVE DISEASE; DNA DAMAGE; INCUBATION TIME; NEUROPROTECTION; OXIDATION; PRIORITY JOURNAL; REDUCTION;

AZOLES; CATIONS, DIVALENT; COPPER; DNA DAMAGE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEUROPROTECTIVE AGENTS; ORGANOSELENIUM COMPOUNDS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLASMIDS;

EID: 0037072567     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00444-5     Document Type: Article

References (21)

1. Alam Z.I., Daniel S.E., Lees A.J., Marsden D.C., Jenner P., Halliwell B.A. Generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69:1997;1326-1329.
2. Alam Z.I., Jenner A., Daniel S.E., Lees A.J., Cairns N., Marsden D.C., Jenner P., Halliwell B. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69:1997;1196-1203.
3. Blum D., Torch S., Lambeng N., Nissou M.F., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65:2001;135-172.
4. Bogdanov M.B., Andreassen O.A., Dedeoglu A., Ferrante R.J., Beal M.F. Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease. J. Neurochem. 79:2001;1246-1249.
5. Ferger B., Rose S., Jenner A., Halliwell B., Jenner P. 6-Hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum. NeuroReport. 12:2001;1155-1159.
6. Hanna P.M., Mason R.P. Direct evidence for inhibition of free radical formation from Cu(I) and hydrogen peroxide by glutathione and other potential ligands using the EPR spin-trapping technique. Arch. Biochem. Biophys. 295:1992;205-213.
7. Kidd P.M. Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management. Altern. Med. Rev. 5:2000;502-545.
8. Levay G., Ye Q., Bodell W.J. Formation of DNA adducts and oxidative base damage by copper mediated oxidation of dopamine and 6-hydroxydopamine. Exp. Neurol. 146:1997;570-574.
9. Li Y., Kuppusamy P., Zweier J.L., Trush M.A. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. Part I. Chemical reactions involved in the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite, 1,4-hydroquinone. Mol. Pharmacol. 49:1996;404-411.
10. Li Y., Trush M.A. DNA damage resulting from the oxidation of hydroquinone by copper: role for a Cu(II)/Cu(I) redox cycle and reactive oxygen generation. Carcinogenesis. 14:1993;1303-1311.
11. Li Y., Trush M.A. Reactive oxygen-dependent DNA damage resulting from the oxidation of phenolic compounds by a copper-redox cycle mechanism. Cancer Res. 54:1994;1895-1898.
12. Moussaoui S., Obinu M.C., Daniel N., Reibaud M., Blanchard V., Imperato A. The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease. Exp. Neurol. 166:2000;235-245.
13. Nagayama T., Lan J., Henshall D.C., Chen D., O'Horo C., Simon R.P., Chen J. Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J. Neurochem. 75:2000;1716-1728.
14. Parnham M., Sies H. Ebselen: prospective therapy for cerebral ischaemia. Expert. Opin. Investig. Drugs. 9:2000;607-619.
15. Rahman A., Shahabuddin, Hadi S.M., Parish J.H., Ainley K. Strand scission in DNA induced by quercetin in the presence of Cu(II): role of Cu(I) and oxygen free radicals. Carcinogenesis. 10:1989;1833-1839.
16. Schewe T. Molecular actions of ebselen - an anti-inflammatory antioxidant. Gen. Pharmacol. 26:1995;1153-1169.
17. Selley M.L. (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic. Biol. Med. 25:1998;169-174.
18. Sies H., Masumoto H. Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite. Adv. Pharmacol. 38:1997;229-246.
19. Spencer J.P.E., Jenner A., Aruoma O.I., Evans P.J., Kaur H., Dexter D.T., Jenner P., Lees A.J., Marsden D.C., Halliwell B. Intense oxidative DNA damage promoted by L-DOPA and its metabolites: implications for neurodegenerative disease. FEBS Lett. 353:1994;246-250.
20. Win W., Cao Z., Peng X., Trush M.A., Li Y. Different effects of genistein and resveratrol on oxidative DNA damage in vitro. Mutat. Res. 513:2002;113-120.
21. Yamamoto K., Kawanishi S. Hydroxyl free radical is not the main active species in site-specific DNA damage induced by copper(II) ion and hydrogen peroxide. J. Biol. Chem. 264:1989;15435-15440.